IP Library › Granted Patent US 11,905,541
Granted Patent B2
US 11,905,541 · App. 17/837,660 · Granted Feb 20, 2024

Efficient product cleavage in template-free enzymatic synthesis of polynucleotides

Inventor: Sandrine Creton (Le Kremlin-Bicêtre, FR)
Assignee: DNA Script SAS
C12P19/14C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,905,541
App. No.
17/837,660
Granted
Feb 20, 2024
Kind
B2
Abstract

The present invention is directed to methods and kits for template-free enzymatic synthesis of polynucleotides that include or enable a step of efficiently cleaving the polynucleotide products from its initiator using an endonuclease V activity and initiator with a 3′-penultimate deoxyinosine.

Claims (18)

1. A method of synthesizing a polynucleotide having a predetermined sequence, the method comprising the steps of:

a) providing an initiator having a 3′-penultimate deoxyinosine and a 3′-terminal nucleotide having a free 3′-hydroxyl;

b) repeating cycles of (i) contacting under elongation conditions the initiator or elongated fragments having free 3′-O-hydroxyls with a 3′-O-blocked nucleoside triphosphate and a template-independent DNA polymerase so that the initiator or elongated fragments are elongated by incorporation of the 3′-O-blocked nucleoside triphosphate to form 3′-O-blocked elongated fragments, and (ii) deblocking the elongated fragments to form elongated fragments having free 3′-hydroxyls, until the polynucleotide is formed, wherein said template-independent DNA polymerase is a terminal deoxynucleotidyl transferase; and

c) treating the polynucleotide with an endonuclease V activity to cleave the polynucleotide from the initiator, wherein said endonuclease V activity is provided by a prokaryotic endonuclease V.

2. The method of claim 1 , wherein said prokaryotic endonuclease V is an E. coli endonuclease V.

3. The method of claim 1 , further comprising a step of removing said prokaryotic endonuclease V from said cleaved polynucleotide.

4. The method of claim 1 , wherein said initiator is attached to a support by a 5′ end.

5. The method of claim 4 , wherein said support is a solid support.

6. The method of claim 1 , wherein said initiator has a 3′-terminal sequence of 5′-dI-dT-3′.

7. The method of claim 1 , wherein said polynucleotide cleaved from said initiator has a 5′-monophosphate.

8. A kit for enzymatically synthesizing a polynucleotide comprising an initiator attached to a support by a 5′ end and having a 3′-penultimate deoxyinosine; a 3′-terminal nucleotide having a free 3′-hydroxyl; an endonuclease V capable of cleaving an initiator-polynucleotide conjugate 3′ of a terminal nucleotide of the initiator; the template-free polymerase terminal deoxynucleotidyl transferase; and a 3′-O-blocked nucleoside triphosphate for one or more of deoxyadenosine, deoxyguanosine, thymidine, deoxyuridine and deoxycytidine.

9. The kit of claim 8 , further comprising said initiator with a 3′-terminal sequence of 5′-dI-dT-3′.

10. The kit of claim 8 , wherein said support is a solid support.

11. The kit of claim 8 , further comprising a de-blocking agent.

12. The kit of claim 8 wherein said 3′-O-blocked nucleoside triphosphate is 3′-O-NH 2 -nucleoside triphosphate.

13. The method of claim 2 , further comprising a step of removing said prokaryotic endonuclease V from said cleaved polynucleotide.

14. The method of claim 2 , wherein said initiator is attached to a support by a 5′ end.

15. The method of claim 14 , wherein said support is a solid support.

Priority Claims (1)
EP 19305174 · Feb 12, 2019 · regional
Continuity (2)
Continuation 16981595
Related Publication 20230105977A1 · Apr 6, 2023
Cited By (1)
US 12,703,860